There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Tenet Healthcare (THC – Research Report) and Elevance Health (ELV – Research Report) with bullish sentiments.
Tenet Healthcare (THC)
In a report released today, Brian Tanquilut from Jefferies maintained a Buy rating on Tenet Healthcare, with a price target of $95.00. The company’s shares closed last Wednesday at $50.56.
According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tenet Healthcare with a $68.43 average price target, which is a 37.0% upside from current levels. In a report issued on January 19, Mizuho Securities also maintained a Buy rating on the stock with a $60.00 price target.
See today’s best-performing stocks on TipRanks >>
Elevance Health (ELV)
In a report released today, David Windley from Jefferies maintained a Buy rating on Elevance Health, with a price target of $578.00. The company’s shares closed last Wednesday at $495.59.
According to TipRanks.com, Windley is a top 100 analyst with an average return of
Elevance Health has an analyst consensus of Strong Buy, with a price target consensus of $580.83, implying a 20.3% upside from current levels. In a report issued on January 11, SVB Securities also reiterated a Buy rating on the stock with a $580.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on THC:
- Tenet Healthcare CFO Daniel Cancelmi retiring at year-end
- Tenet Healthcare now sees 2022 adjusted EBITDA above $3.425B guidance midpoint
- Greenlight took ‘medium-sized’ Tenet Healthcare position in Q4, Bloomberg says
- Tenet Healthcare price target raised to $60 from $55 at Truist
- Tenet Healthcare price target raised to $45 from $40 at Loop Capital
